abrdn Healthcare Opportunities Fund — Cyborg Score 6/10
Solid
Mutual Funds
Strategic Profile
The fund invests at least 80% of its Managed Assets in U.S. and non-U.S. healthcare companies through equity securities, debt securities, and pooled investment vehicles. The fund maintains a stable distribution policy with monthly distributions currently set at $0.18 per share.
Cyborg Score Rationale
As a diversified closed-end healthcare fund with stable distributions, the fund benefits from broad sector exposure and professional management. However, recent six-month performance (March 31, 2026) lagged its benchmark, and closed-end funds are subject to market volatility and discount-to-NAV risks.
Top Insights
Six-month total return through March 31, 2026 was 3.15% (NAV basis), underperforming its blended benchmark of 5.14% (May 2026)
Portfolio includes corporate debt securities across the credit rating spectrum alongside equities
Fund benchmarks against S&P 1500 Healthcare Index and S&P 500 Index
Fund established April 2, 2014 with over a decade of healthcare sector investment history
Named Competitors
Healthcare Investors — Healthcare-focused closed-end fund (HQH)
Life Sciences Investors — Life sciences-focused closed-end fund (HQL)
Recent Developments
(March 2026) Semi-annual report filed showing stable distribution policy of $0.18 per share monthly
(April 2026) Fund announced updates to abrdn U.S. closed-end funds reporting
Open the full interactive abrdn Healthcare Opportunities Fund report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.